Cell line models of leukemia

Drug Discovery Today: Disease Models

Volumn 2, Issue 1, 2005, Pages 51-56

  Drexler, Hans G ^a   Quentmeier, Hilmar ^a   MacLeod, Roderick A F ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; FLT3 LIGAND; MIXED LINEAGE LEUKEMIA PROTEIN; MYC PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER MODEL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CLINICAL RESEARCH; CRYOPRESERVATION; DRUG TARGETING; GENE EXPRESSION PROFILING; HEMATOLOGIC DISEASE; HUMAN; LEUKEMIA CELL LINE; LEUKEMOGENESIS; MOLECULAR BIOLOGY; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE;

EID: 21644469570     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2005.05.010     Document Type: Review

References (19)

1. H.G. Drexler and J. Minowada History and classification of human leukemia-lymphoma cell lines Leukemia Lymphoma 31 1998 305-316
2. H.G. Drexler et al. Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research Leukemia Res. 24 2000 881-911
3. H.G. Drexler Establishment and culture of human leukemia-lymphoma cell lines In: R. Pfragner R.I. Freshney eds. Culture of Tumor Cells 2003 Wiley 319-348
4. H.G. Drexler and Y. Matsuo Guidelines for the characterization and publication of human malignant hematopoietic cell lines Leukemia 13 1999 835-842
5. H.G. Drexler et al. Mix-ups and mycoplasma: The enemies within Leukemia Res. 26 2002 329-333
6. H.G. Drexler et al. Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines Leukemia 9 1995 480-500
7. T. Akasaka et al. BCL6 gene translocation in follicular lymphoma: A harbinger of eventual transformation to diffuse aggressive lymphoma Blood 102 2003 1443-1448
8. O.A. Bernard et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia Leukemia 15 2001 1495-1504
9. S. Nagel et al. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2) Cancer Res. 63 2003 5329-5334
10. R.A.F. MacLeod et al. Activation of HOX11L2 by juxtaposition with 3′-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2) Genes Chromosomes Cancer 37 2003 84-91
11. L.M. Kelly and D.G. Gilliland Genetics of myeloid leukemias Annu. Rev. Genomics Hum. Genet. 3 2002 179-198
12. L. Degos et al. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia Blood 85 1995 2643-2653
13. T.R. Breitman et al. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid Proc. Natl. Acad. Sci. USA 77 1980 2936-2940
14. H. Quentmeier et al. FLT3 mutations in acute myeloid leukemia cell lines Leukemia 17 2003 120-124
15. M. Levis and D. Small FLT3: ITDoes matter in leukemia Leukemia 17 2003 1738-1752
16. B.J. Druker et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells Nat. Med. 2 1996 561-566
17. Deininger M. et al. (2005) The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 105, 2640-2653
18. C. Graux et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukaemia Nat. Genet. 36 2004 1084-1089
19. R. Sandberg and I. Ernberg Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI) Proc. Natl. Acad. Sci. USA 102 2005 2052-2057